A mixture of antibiotics for the sterilisation of valve allografts was first described by Barratt- Boyes and Roche (1969) . Other mixtures have since been described (for example, Lockey et al., 1972; Yacoub et al., 1973; Waterworth et al., 1974) . At the National Heart Hospital six different mixtures have been used to treat heart valve allografts over the past seven years. The Barratt-Boyes formula (1969) was found to be unsuitable, and Lockey et al. (1972) formulated an alternative mixture, 'B', which was used for three years and was then changed to the mixture 'C' described by Waterworth et al. (1974) . This mixture, like that of Yacoub and Kittle (1970) amphotericin B (Yacoub et al., 1973) was not satisfactory in controlling fungal contamination, the incidence of which was 15% (Table 2) . At the Harefield Hospital the valves are kept in the antibiotic mixture of Yacoub et al. (1973) for 24 hours and then transferred for subsequent storage to a nutrient medium containing nystatin (Yacoub, personal communication) . The elective omission of this transfer step to nystatin was an obvious contributory factor to the 15% withdrawal rate presented in Table 2 . HANYNM (Table 1) has proved satisfactory with the replacement of amphotericin B by nystatin (Table 2 ). Table 2 shows that although NYDANM was effective in controlling contaminating bacteria, the lower concentration of nystatin (0-1 g/l) in NYDANM was not effective in controlling fungal contamination. For this reason the medium was changed to DANYNM (dilute antibiotics with nystatin in nutrient medium) (Table 1) , in which the high concentration of nystatin in HANYNM (0 5 g/l) was used. DANYNM is now in routine use at the National Heart Hospital for the treatment of heart valve allografts and has given only a 3% rate of withdrawal. This medium still has a high cytotoxic level of nystatin. The concentrations of the antibiotics have been reduced to a rational level, avoiding some cytotoxicity (eg, from cephaloridine). It is estimated that the change from HANYNM to DANYNM will save £1000 per annum in the treatment of 300 heart valves. This combination of antibiotics retains its antibacterial effectiveness during seven days' storage at +4°C. The other important issue which was raised by the failure of the mixture described by Waterworth et al. (1974) was the absolute necessity for routine microbiological screening. Waterworth et al. (1974) correctly pointed out that such screening was misleading in view of the carry-over of antibiotics from the sterilising mixture to the bacteriological growth medium. However, the tests of Waterworth et al. (1974) detected organisms resistant to their mixture 'C' of antibiotics. Also, at the National Heart Hospital, strains of Pseudomonas spp resistant to both gentamicin and polymyxin were seen as cloudy growths in media containing valves treated with the same antibiotic mixture 'C'. Because of this resistant contamination many valves in the Waterworth et al. (1974) mixture 'C' were discarded ( Table 2 ). The simultaneous occurrence of contaminating fungi in the Waterworth et al. (1974) mixture 'C' (Table 2) more of those fungi had a low sensitivity to nystatin, but this was not investigated at that time.
The re-introduction of routine microbiological screening of heart valve allografts in this hospital has resulted in the withdrawal prior to clinical use of a number of valves: 35 of 230 valves treated with the Harefield antibiotic mixture (described by Yacoub et al. (1973) ), 5 out of 233 valves treated with HANYNM, and 5 out of 150 valves treated with DANYNM (Table 2) . Forty-two of these 45 withdrawals were due to the presence of fungi on the valve tissue. Two isolates of Candida species proved to be peculiarly resistant to the antifungal agent, nystatin, without any prior exposure to the drug. The MIC of this drug for these two particular isolates was 0 025 g/l yet they survived treatment in a medium containing 05 g nystatin per litre (HANYNM). Three withdrawals were due to bacterial contamination. These were: one Strep. faecalis, resistant to polymyxin, neomycin, and cephaloridine; one coliform bacillus, resistant to carbenicillin and cephalothin; and one Grampositive coccus, the identification tests and sensitivities for which were not carried out.
We therefore wish to emphasise the importance of routine microbiological screening of heart valve allografts, or any other tissues for clinical use, which have been treated with high concentrations of antibiotics. This emphasis is in direct conflict with the views of Waterworth et al. (1974) but reinforces the doubts of Lockey (1975) ; '. . . the author does not think that antibiotics can be relied upon unfailingly to sterilise homograft tissues'. However, provided that there is adequate microbiological testing of each valve, high concentrations of antibiotics may be used as one way of treating heart valves intended for surgery, and we propose to continue to use this method. 
